Navigation Links
BioConvergence®, Contract Manufacturing Organization for the Life Sciences Industry, Announces New Board of Directors
Date:9/19/2013

Bloomington, IN (PRWEB) September 19, 2013

BioConvergence publicly announced today that they have appointed a new Board of Directors. Kathy Jackson was named as Chair, with Dr. Rafik Bishara, Ken Martlage, and Alisa Wright as board members.

Jackson is a senior executive consultant and a principal with Compete Indiana, LLC. She helps growing organizations to identify and correct strategic gaps within their businesses, especially when pertaining to employee care and customer satisfaction. Jackson guides her clients with the best practices and expertise she utilized over the past 12 years in her senior-level executive positions (including President and CEO of Novia CareClinics, LLC) and in her nearly 20 years spent as an educator.

Bishara is a well-known expert in the pharmaceutical supply chain distribution sector. His specialty of Good Cold Chain and Temperature-Controlled Management has led to numerous industry contributions. He has served on the board or as an advisor to many organizations (including Sensitech, Inc., Cryoport, and the World Health Organization); he is also the current Chair of the Pharmaceutical Cold Chain Interest Group (PCCIG) within the Parenteral Drug Association (PDA). He spent 35 years at Eli Lilly & Co. as Director, Quality Knowledge Management, and Technical Support.

Martlage coaches individuals, teams, and corporations in leadership development. He spent 28 years at Eli Lilly & Co. in various management positions and retired in 2000. The past 13 years have been dedicated to international consulting across multiple industries with Compete Indiana, LLC; Phoenix Images, Inc., and Tercon Consulting. His experience includes coaching senior management, team alignment, and facilitating organizational culture shift. Martlage also spent 12 years as a lecturer at Indiana University-Purdue University Indianapolis (IUPUI).

Alisa Wright, CEO of BioConvergence, said of her fellow board members and of the announcement in general:

“BioConvergence is thrilled that our Board is comprised of people with the passion and know-how needed to take our firm to the next level. In the last year, each of the board members has been collaborating with internal teams to improve operations. Because of what we have accomplished, I am anticipating more great things for the Company and its clients in the coming year.”

Wright notes that the backgrounds and experience levels of the Board’s members will support and compliment the Company’s objectives.

Wright began her career in the pharmaceutical industry with firms such as Eli Lilly & Co., Cook Pharmaceutical Solutions, and Baxter Pharmaceutical Solutions. During her 25 years of experience, she identified many industry gaps; in response, she founded BioConvergence to help companies consolidate their supplier base, mitigate risk, and speed products to market, all in an effort to provide patients with better healthcare treatments. BioConvergence is in its seventh year of service.    

Erick Ponader, Partner at Taft Stettinius & Hollister LLP, continues to serve BioConvergence as General Counsel.

For more information, please visit http://bioc.us/about-us/board-of-directors/

About BioConvergence

BioConvergence is a contract manufacturing organization for the life sciences industry, offering outsourcing partnerships for formulation development, testing, production, and supply chain services. Headquartered in Bloomington, Indiana, they have over 50 employees with five centuries’ worth of combined experience in the pharmaceutical industry. Their unique E-Transparency® System provides transparency and flexibility to their clients, while offering superior, quality-driven outsourcing services. For more information, visit http://www.bioc.us.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11142351.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. HerbalGram Article Details Procedures for Choosing a Contract Analytical Lab for Dietary Ingredients
2. Bio/Pharmaceutical Contract Manufacturing - Industry Analysis of Dose Manufacturing by the Numbers: Composition, Size, Market Shares, Profitability and Outlook
3. Pharma Contract Manufacturing, Research & Packaging Market a New Report Available at ReportsnReports.com
4. Indiana University Contracts with Virtify for Clinical Trial Disclosure Solutions
5. Fortune 500 Company Contracts with Wireless Analytics to Extend Wireless Expense Management & Mobility Management Services Internationally
6. Boehringer Laboratories LLC Awarded HPG Contract for Clinical Suction Regulators
7. PharmSource CMO-CDMO Database Expands Coverage to Include Approved Pharmaceutical Products: Intelligence Resource for Analyzing Bio/Pharmaceutical Contract Manufacturing
8. Clinical Development, Contracts and Outsourcing in MENA & APAC, New Webinar Hosted by Xtalks
9. ChanTest Develops New Cardiotoxicity and Contractility Assay with Human Stem Cell Cardiomyocytes
10. Non-Intrusive Rust Remover Gives Out New Set of Samples to Rust Contractors, My Cleaning Products Says the Spray Cuts $1,000s of Rust Removal Expense
11. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Three-Year Initiative Supports Next Generation of ... in Life-Changing Camp Experiences ... affect the lives of children born with rare diseases, as well ... ) is announcing a new initiative designed to positively affect the ... future of rare disease care. --> To mark the ...
(Date:2/8/2016)... BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced ... companies in the TSX Venture 50 TM . ... TSX Venture Exchange, in each of five major industry sectors ... life sciences, diversified industries and technology – based on a ... market cap growth, trading volume and analyst coverage. All data ...
(Date:2/8/2016)... February 8, 2016 ... Limited, an innovation-driven oncology company developing next generation ... toxic, today announced that chairman emeritus of Tata ... in the company as part of the first ... existing investors Navam Capital and Aarin Capital. ...
(Date:2/8/2016)... 2016  BioElectronics Corporation (OTC Pink: BIEL), the ... that it is responding to a notice of ... and Exchange Commission posted on the agency website.  ... the Board of BioElectronics Corporation and the Edward ... The Fuqua School of Business, Duke University.   ...
Breaking Biology Technology:
(Date:1/20/2016)... JOSE, Calif. , Jan. 20, 2016 /PRNewswire/ ... developer of human interface solutions, today announced sampling ... controller solution for wearables and small screen applications ... such as printers. Supporting round and rectangular shapes, ... S1423 offers excellent performance with moisture on screen, ...
(Date:1/13/2016)... January 13, 2016 ... addition of the  "India Biometrics Authentication ... Forecast (2015-2020)"  report to their ... has announced the addition of the  ... - Estimation & Forecast (2015-2020)" ...
(Date:1/8/2016)... , January 8, 2016 ... market and WorldVentures ® , a privately held leading ... an Inc. 5000 fastest-growing company announced that ... investment of $2 million in Nxt-ID to develop a ... on Nxt-ID,s Wocket ® , a unique smart wallet ...
Breaking Biology News(10 mins):